Invivo Capital Partners

Type

Venture Capital

Status

Active

Location

Barcelona, Spain

Total investments

17

Average round size

11M

Portfolio companies

11

Lead investments

5

Follow on index

0.35

Areas of investment
BiotechnologyDrug DiscoveryInternetFood and BeverageHealth CareGeneticsLife SciencePharmaceuticalTherapeuticsAgriculture

Investor highlights

Industry focus
Biotech/Life SciencesHealthcare
Stage focus
Pre-SeedSeedSeries A
Geo focus
AlbaniaAndorraAustriaBelgiumBosnia and Herzegovina Show 39 more
Check size
2M — 4M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
17
Lead investments
5
Follow on index
0.35
Investments by industry
  • Biotechnology (13)
  • Life Science (3)
  • Pharmaceutical (3)
  • Therapeutics (3)
  • Drug Discovery (2)
  • Show 5 more
Investments by region
  • France (3)
  • Spain (12)
  • Belgium (1)
Peak activity year
2020

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
3
Group Appearance index
0.71

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Aequilibrium 01 Apr 2022 Software, Information Services, Augmented Reality Seed 25K United States, Illinois, Chicago
Reputation.com 01 May 2009 Internet, Analytics, SaaS, Enterprise Software, Social Media, SEO, Reputation Early Stage Venture 4M United States, California, Redwood City
Telomere Therapeutics 01 Dec 2020 Biotechnology Seed 1M Barcelona, Catalonia, Spain
Telomere Therapeutics 25 May 2021 Biotechnology Seed 2M Barcelona, Catalonia, Spain
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.